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Accumulating evidence indicates that the intestinal microbiota regulates our 
physiology and metabolism. Bacteria marketed as probiotics confer health benefits 
that may arise from their ability to affect the microbiota. Here high-throughput 
screening of the intestinal microbiota was carried out and integrated with serum 
lipidomic profiling data to study the impact of probiotic intervention on the intestinal 
ecosystem, and to explore the associations between the intestinal bacteria and serum 
lipids. We performed a comprehensive intestinal microbiota analysis using a 
phylogenetic microarray before and after Lactobacillus rhamnosus GG intervention. 
While a specific increase in the L. rhamnosus-related bacteria was observed during 
the intervention, no other changes in the composition or stability of the microbiota 
were detected. After the intervention, lactobacilli returned to their initial levels. As 
previously reported, also the serum lipid profiles remained unaltered during the 
intervention. Based on a high-resolution microbiota analysis, intake of L. rhamnosus
GG did not modify the composition of the intestinal ecosystem in healthy adults, 
indicating that probiotics confer their health effects by other mechanisms. The most 
prevailing association between the gut microbiota and lipid profiles was a strong 
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positive correlation between uncultured phylotypes of Ruminococcus gnavus-group 
and polyunsaturated serum triglycerides of dietary origin. Moreover, a positive 
correlation was detected between serum cholesterol and Collinsella 
(Coriobacteriaceae). These associations identified with the spectrometric lipidome 
profiling were corroborated by enzymatically determined cholesterol and triglyceride 
levels. Actinomycetaceae correlated negatively with triglycerides of highly
unsaturated fatty acids while a set of Proteobacteria showed negative correlation with 
ether phosphatidylcholines. Our results suggest that several members of the 
Firmicutes, Actinobacteria and Proteobacteria may be involved in the metabolism of 
dietary and endogenous lipids, and provide a scientific rationale for further human 
studies to explore the role of intestinal microbes in host lipid metabolism.
Introduction
Over 90% of the cells in the human body constitute microbes, the majority of them 
living in the lower part of the gastrointestinal (GI) tract. Hence, we are composite 
organisms programmed not only by the inherited and stable human genome but also 
by the environmentally acquired and plastic microbiome. The coding capacity of the 
microbiome vastly surpasses the human genome with more than three million genes 
(Qin et al., 2010). While many of the microbial functions have not yet been
characterized, various mechanisms have been described by which the intestinal
microbes impact our life, including the metabolism of our food, exclusion of pathogens 
and many signaling functions that range from modulation of the mucosal immune 
response to development of metabolic diseases (Holmes et al., 2011; Sekirov, 2010).
Bacterial metabolism of dietary and endogenous substances is known to generate a
wide repertoire of metabolites that may have beneficial or harmful effects on the host 
(O’Keefe, 2008; Blaut & Clavel, 2007). Hence, the intestinal microbiota has a 
remarkable potential to influence the physiology and biology of the host (Tremaroli & 
Bäckhed, 2012), and unlike the human genome, its gene pool can be modulated by 
changing the environmental conditions, such as food or drug intake, affecting the 
composition and function of the intestinal microbiota (Zoetendal, Rajilić-Stojanović & 
de Vos, 2008).
Consumption of lactic acid bacteria marketed as probiotics is a common approach to 
maintain health (Saxelin et al., 2005). Lactobacillus rhamnosus GG is one of the most 
widely used probiotic bacteria that is assumed to interact with the host via binding to
human mucus via its extracellular pili (Kankainen et al., 2009). However, the further 
molecular details of the probiotic signaling are not yet understood and it remains to be 
established whether the effect is direct, through metabolites or structural components 
modulating for instance the immune responses of the host or indirect, via alteration of 
the intestinal microbiota. From the ecological perspective, a single bacterial strain is 
not likely to radically alter the established intestinal community, which in adults 
typically consists of hundreds of different species-level phylotypes that represent 
approximately ten bacterial phyla, vastly dominated by Firmicutes, Bacteroidetes and 
Actinobacteria, followed by Proteobacteria, Fusobacteria and Verrucomicrobia 
(Zoetendal, Rajilić-Stojanović & de Vos, 2008). Many of the currently characterized
phylotypes are strict anaerobes, have not yet been cultured, and can only be
recognized based on molecular methods (Zoetendal, Rajilić-Stojanović & de Vos, 
2008). The development of culture-independent molecular techniques has provided 
insights in the composition of the intestinal microbiota before and following probiotic 
intake. Targeted microbiota analyses as well as the more recent community-level
profiling studies support the view that the effects of probiotic intake are limited and 
only affect bacteria related to the probiotics (Satokari et al., 2001; Vaughan, Mollet & 
de Vos, 1999; Palaria, Johnson-Kanda & O’Sullivan, 2011; McNulty et al., 2011).
Animal and in vitro studies have shown that the intestinal microbiota can regulate host
lipid metabolism via numerous microbial activities (Fava, 2006; Martin et al., 2007). 
The best characterized mechanism is through the biotransformation of bile acids, 
which regulates the digestion and absorption of fats, and profoundly affects the 
cholesterol and other lipid metabolism in the body (Gérard, 2010; Ridlon, Kang & 
Hylemon, 2006). However, global monitoring of the serum and organ lipid profiles of 
germ-free and conventionally raised mice suggests an even more widespread and 
profound influence of the intestinal microbiota on host lipid metabolism, in particular 
on triglycerides and phosphatidylcholines (Velagapudi et al., 2010; Orešič, Hänninen, 
& Vidal-Puig, 2008).
In the present study, we characterized the impact of a probiotic intervention on the 
composition and stability of the intestinal microbiota and serum lipid profiles in healthy
adults. A comprehensive intestinal microbiota profiling and phylogenetic analysis was 
carried out with the Human Intestinal Tract Chip (HITChip), a phylogenetic microarray 
that provides a robust and sensitive measurement platform to assessing the 
abundance of over 1000 microbial species-like phylotypes representing the majority 
of the known bacterial diversity of the human intestinal tract (Rajilić-Stojanović et al., 
2009). Stability of the microbiota was quantified by inter- and intra-individual 
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correlations within and between time points. The study subjects were sampled prior 
and after three weeks consumption of dairy milks supplemented with either the 
probiotic L. rhamnosus GG or a placebo. Moreover, the microbiota composition was 
analyzed from follow-up samples collected three weeks after the intervention trial. 
With phylogenetic microarray analysis we could both deepen and expand the typical 
bacterial analysis in probiotic trials, often limited to specific bacterial groups, such as 
lactic acid bacteria, or to the dominant fraction of the microbiota. Previously, we have 
shown that the intake of L. rhamnosus GG did not elicit any significant changes in the 
serum lipids (Kekkonen et al., 2008b). The present study complements these results 
by providing longitudinal data and evidence that the probiotic intervention with L.
rhamnosus GG does not affect the overall composition or stability of the intestinal 
microbiota. Furthermore, we have integrated the lipid profiling and global microbiota 
data sets to investigate the overall associations between the intestinal microbes and 
systemic metabolites, in particular serum lipids. Quantitative analyses suggest that 
the abundance of specific intestinal microbes is correlated to that of specific lipid 
species. We identified mainly uncultured members of the Firmicutes, Actinobacteria 
and Proteobacteria that seem to be involved in the absorption and metabolism of the 
dietary and endogenous lipids, providing a scientific rationale for further human 




The trial and its protocol have been approved by the Ethics Committee of the Hospital 
District of Helsinki and Uusimaa (Ethical protocol no HUS 357/E0/05). The subjects 
provided written informed consent. The details of this trial have been published 
previously (Kekkonen et al., 2008a; Kekkonen et al., 2008b).
Subjects
The subjects were healthy Finnish adults (n = 25, 18 females, 7 males) with a mean 
age of 42 years (23–55) and a mean BMI of 24 kg/m  (18–30) from Helsinki region,
representing a subset of a larger cohort (Kekkonen et al., 2008a; Kekkonen et al., 
2008b). The CONSORT flowchart (Fig. 1) summarizes the subject enrollment, 
intervention allocation, follow-up, and data analysis during the study. The subject 
characteristics are provided in Supplemental Table S1.
Figure 1: Flowchart of the study subjects during the trial.
DOI: 10.7717/peerj.32/fig-1
Dietary intervention
The subjects constituted two treatment groups in a randomized, double blind 
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intervention study to receive either L. rhamnosus GG (probiotic; n = 11) or placebo
(n = 14). During the intervention the subjects consumed daily a 250 mL milk-based 
fruit drink containing either L. rhamnosus GG (ATCC 53103, 6.2 × 10  cfu/mL) or a 
similar placebo drink without probiotic bacteria for three weeks. No other probiotic-
containing products were allowed three weeks prior or during the intervention; a list of 
fermented foods and commercial probiotic-containing products was given to the 
subjects. The subjects were not separately questioned about their abstinence from 
probiotic products, but they filled a study diary recording the daily intake of the study
product.
Fecal samples and microbiota analysis with the HITChip 
and quantitative PCR
Three fecal samples per individual were collected three weeks before, during and 
three weeks after the intervention, as previously described (Kekkonen et al., 2008b). 
The fecal DNA extraction with modified Promega method, and quantification of the 
probiotic counts with a strain-specific quantitative PCR (qPCR) assay have been 
described previously (Ahlroos & Tynkkynen, 2009). The phylogenetic analysis of the 
intestinal microbiota composition with the HITChip microarray was performed as 
previously described (Rajilić-Stojanović et al., 2009; Salonen et al., 2010). The 
phylogenetic HITChip microarray targets the V1 and V6 hypervariable regions of the 
16S rRNA gene of over 1000 bacterial phylotypes that present the majority of the so 
far detected phylotypes of the human intestine. Phylogenetic organization of the 
microarray probes and data preprocessing have been explained in detail elsewhere 
(Rajilić-Stojanović et al., 2009; Salonen et al., 2010; Jalanka-Tuovinen et al., 2011). 
Quantification of the relative differences in the taxon abundance between samples 
was obtained by summarizing the probe signals to phylotype (species-like), genus 
and phylum levels. Genus-level taxa with ≥ 90% sequence similarity in the 16S rRNA 
gene are referred to as Species and relatives, the latter being shortened in the text as 
“et rel.” (Rajilić-Stojanović et al., 2009).
Previously, HITChip-derived microbial profiles have been shown to correlate well with 
those obtained with fluorescence in situ hybridization (FISH) (Rajilić-Stojanović et al., 
2009) and pyrosequencing (Claesson et al., 2009). Samples were also used for 
absolute quantification of total bacteria, methanogenic Archaea, Lactobacillus group 
and Bifidobacterium spp. with previously described qPCR primers and reaction
conditions (Salonen et al., 2010).
Blood samples and their biochemical analyses
Of the 25 study subjects used for the microbiota analysis, 22 (8 from probiotic group 
and 14 from placebo group) were available for the parallel analysis of serum lipid 
profiles before and after the intervention (44 samples in total). Venous blood samples 
from the antecubital vein were taken at baseline and after the three-week 
intervention. The blood samples were stored at −20 °C for further analyses. Total
cholesterol, high-density lipoprotein (HDL) and low-density lipoprotein (LDL)
cholesterol as well as triglyceride levels were enzymatically determined from the 
serum as previously described (Kekkonen et al., 2008a).
Global lipid profiling: sample preparation and analysis by 
UPLC-MS
Extraction of lipids from the serum samples, analysis of the lipid extracts with Waters 
Q-Tof Premier mass spectrometer combined with an Acquity Ultra Performance LC
(UPLC), data preprocessing and identification of the lipid molecular species is 
described in detail elsewhere (Kekkonen et al., 2008a). Lipids have been named 
according to Lipid Maps (http://www.lipidmaps.org) with the following abbreviations: 
Cer: ceramide; ChoE: cholesteryl ester; lysoPC: lysophosphatidylcholine; PA: 
phosphatidic acid; PG: phosphatidylglycerol; PC: phosphatidylcholine; PS: 
phosphatidylserine; SM: sphingomyelin; TG: triglyceride. Where the fatty acid 
composition could not be determined, the total number of carbons and double bonds 
is indicated. The first number indicates the amount of carbon atoms in the fatty acid 
molecule, followed by the number of double bonds.
Statistical analyses
The effects of probiotic intervention on the intestinal microbiota were investigated with 
a combination of linear models, sparse principal component analysis (PCA; Shen & 
Huang, 2008; Lê Cao, González & Dèjean, 2009), unsupervised hierarchical 
clustering, and significance testing. The log-transformed HITChip and lipid profiling 
values were approximately Gaussian distributed and fulfilled the general statistical
assumptions underlying the selected computational approaches. Background
variables, including age, body-mass index and gender were compared in the baseline 
samples to exclude potentially confounding effects associated with these variables. 
The Wilcoxon test was used with continuous variables and the Fisher exact test for 
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categorical variables, followed by Benjamini–Hochberg p-value correction for multiple 
testing. No significant differences between the background variables were observed 
between the treatment groups (p > 0.05 in all comparisons). The two-group 
comparisons between the time points and between the treatment groups were 
quantified based on a linear model with group-wise fixed effects and sample-specific 
random effects, as implemented in the limma R package (Smyth, 2004), to identify 
bacterial taxa with significant changes induced by the probiotic intervention and to 
assess the magnitude and significance of the effects. The function lmFit was used to 
fit the linear model, followed by significance estimation by empirical Bayes as 
described in Smyth (2004). In addition, power calculation was carried out to assess 
statistical power of the current study. The original data was randomly permuted, one
significant 2-fold alteration was inserted, and Gaussian noise was added using the 
same average standard deviation as in the original data. Empirical power calculation 
with 1000 random permutations showed that 2-fold and higher alterations that follow 
the noise levels in the original data were detected in > 99.8% of the cases with 
sample size of 8 or more, based on the same detection criteria than in the current 
study, confirming the high statistical power of the analysis at the present sample size. 
PCA is a linear dimension reduction method used to compress information in the 
high-dimensional phylogenetic (genus-level) and lipid profiles into few informative 
features that capture the main variation in the data and allow two-dimensional 
visualization of sample similarities. The temporal and inter-individual similarity of the
microbiota and lipid profiles was assessed by average intra- and inter-individual 
Pearson correlations (r) between and within the time points, respectively. The 
differences in profile similarity between the probiotic and placebo groups were 
estimated with Wilcoxon test. The biweight midcorrelation, which is more robust to 
outliers than the standard Pearson correlation, was used to quantify correlation 
between the microbiota and lipid profiles across the individuals. High-throughput 
screening studies involve considerable multiple testing and the traditional multiple 
testing correction approaches are prohibitively conservative in this context due to their
emphasis on estimating the probability of a single false positive finding. Hence, we 
have used q-values for multiple testing correction in the high-throughput screening 
tests that include parallel comparisons of large numbers of lipids and bacterial 
phylotypes.
Correlation analysis of the intestinal microbiota and 
serum lipids
The biweight midcorrelation measure was used to quantify associations between the 
microbiota and lipid profiling data sets, and between the microbiota and biochemically 
determined lipids. The correlations between genus-level bacterial groups and lipid 
species were calculated together with significance estimates that were corrected for 
multiple testing. The significantly correlated (q < 0.05) phylotypes and lipids were 
selected for further analysis. It is important to note, however, that while the present 
sample size of 22 samples across 2 time points (before and during the probiotic 
intervention) is sufficient for highlighting significant correlation patterns, the present 
experimental design cannot uncover causal relationships and the observed 
correlations may be partly associated with diet or other confounding variables that 
simultaneously affect both lipid and microbiota profiles. Two-way average linkage 
hierarchical clustering of the bacterial taxa and lipids was applied to highlight and 
visualize groups of phylotypes and lipids sharing similar correlation patterns. 
Analogous ‘second-order’ correlations have previously been applied for instance in 
the context of gene expression studies (Parmigiani et al., 2004; Lahti et al., 2013). A 
constant plaid model biclustering was used for systematic detection of significantly 
correlated bacterial and lipid groups on the correlation heatmap (Lazzeroni & Owen, 
2002). To interpret the detected biclusters, statistical enrichment (over-
representation) of the implicated bacteria was quantified. Moreover, enrichment 
analysis was carried out for lipids containing even or odd number of carbon atoms, as 
well as the enrichment of lipids with zero, one or more double bonds. The enrichment 
analyses were carried out with Fisher’s exact test (Rivals et al., 2007). All analyses 
were performed within the R statistical environment (R Development Core Team, 
2010).
Results
Impact of the L. rhamnosus GG intervention in the
intestinal microbiota
This study characterized the impact of L. rhamnosus GG intervention on the stability 
and composition of the intestinal microbiota. The subjects in the probiotic group 
consumed daily approximately 10  (10.2log ) colony forming units (cfu) of L.
rhamnosus GG. The compliance was verified with the quantification of L. rhamnosus
GG in the feces with strain-specific qPCR (Kekkonen et al., 2008b). The average 
excretion of L. rhamnosus GG in the probiotic group was more than 1000-fold higher 
10
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than that in the placebo group (8.52; sd 0.73log  versus 5.20; sd 1.09log  genome
copies per gram of feces, respectively).
The stability of the microbiota during the trial was quantified by the similarity of the 
microbiota profiles between the three time points with Pearson correlation (Table 1). 
The average intra-individual correlations were high; 0.94–0.95 (sd 0.02–0.03). No 
significant difference in the temporal stability of the microbiota between the probiotic 
and placebo groups was observed, indicating that the probiotic intervention did not 
alter the overall microbial stability. Principal Component Analysis (PCA) visualization 
of the relationships between the intestinal microbiota profiles (Fig. 2A) and 
hierarchical clustering (data not shown) further supported the conclusion that there 
were no systematic differences in the microbiota between the intervention groups. 
The average inter-individual microbiota correlation was 0.76–0.78 with no significant 
differences between the probiotic and placebo groups (Table 1). The intra-individual 
microbiota correlations (r = 0.94–0.95) were notably higher than the inter-individual 
correlations (r = 0.76–0.78), stressing the subject-specificity of the microbiota.
Table 1: 
Stability of microbiota and lipid profiles in the probiotic and placebo groups.
We determined the similarity (expressed as Pearson’s correlation) both within and 
between the time points (TP) for the microbiota and lipid profiles by the average 
scatter r of the profiles. Lipid data is available for the first two time points (TP1 and 
TP2, three weeks before the intervention and during the intervention, respectively), 
and not available (−) for the third time point (TP3) measured three weeks after the 
intervention.
DOI: 10.7717/peerj.32/table-1
Linear models were used to quantify the effects of the L. rhamnosus GG intervention 
on individual taxa using genus- and phylotype-level microarray data. A specific and 
transient increase of bacteria related to L. rhamnosus was detected in the probiotic 
group immediately after the intervention (Fig. 2). There were no intervention-related 
effects in the other lactobacilli, Bifidobacteria or any other taxa either in the probiotic 
or placebo group; however substantial individual variation was evident.
Figure 2: Intervention effects on the abundance of L. rhamnosus.
Between subjects Within subjects
Microbiota TP1 TP2 TP3 TP1 vs TP2 TP3 vs TP2
Probiotic 0.78 0.78 0.78 0.94 0.95
Placebo 0.76 0.77 0.77 0.94 0.95
Lipids
Probiotic 0.90 0.89 – 0.92 –
Placebo 0.91 0.89 – 0.93 –
10 10
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Mean abundance of L. rhamnosus among the study subjects before, during and after 
the probiotic intervention (the time points 1–3, respectively) quantified by the HITChip 
hybridization signal. The error bars denote the Gaussian 95% confidence limits based 
on standard deviation of the mean.
DOI: 10.7717/peerj.32/fig-2
To complement the HITChip microarray analysis, we also determined the absolute
counts of total bacteria, methanogenic Archaea, Lactobacillus group and
Bifidobacterium spp. using real-time PCR. The ingestion of L. rhamnosus GG was 
reflected in the total lactobacilli that showed a highly significant increase in the 
probiotic group after the intervention, returning to baseline levels in the follow up 
(q < 0.05 in both comparisons). No other significant changes were observed in the 
amount of targeted microbes neither in the probiotic or placebo group. We detected
substantial inter- and intra-individual variation in the methanogenic Archaea but that 
was independent of the time point or the treatment group (data not shown). These 
observations support the conclusion that the L. rhamnosus GG intervention did not 
change the overall microbiota composition.
High-throughput profiling of serum lipids
Global profiling of the serum lipids was performed using the UPLC-MS platform to 
assess the serum lipid profiles at the molecular species level (Kekkonen et al., 
2008a). In total, 407 lipid species from 11 different classes were identified. The lipid 
profiles were dominated with triglycerides (TG; 37%), phosphatidylcholines (PC; 25%) 
and phosphatidyletanolamines (PE; 13%) while phosphatidic acids (PA), 
phosphatidylglycerols (PG), sphingomyelins (SM), cholesteryl esters (ChoE), 
lysophosphatidylcholines (lysoPC), phosphatidylserines (PS), ceramides (Cer) and 
lysophosphatidylethanolamines (lysoPE) each contributed with 7% to 0.3% to the 
total lipid pool.
The stability of the lipid profiles was quantified based on the same correlation analysis 
approach than in the HITChip microbiota profiling analysis. No significant differences 
in the lipid profile stability were observed between the treatment groups (average 
intra-individual r = 0.92 and r = 0.93 for the probiotic and placebo groups, 
respectively; Table 1). In contrast to microbiota profiles, the serum lipid profiles were 
remarkably similar not only within the subjects but also between the subjects 
(average inter-individual r = 0.89–0.91; Table 1). No significant differences were seen 
between the probiotic and placebo groups, or between the time points. The stability of 
the lipid and microbiota profiles showed a weak positive correlation (r = 0.27) across 
the subjects independent of a treatment group. The global lipid profiles did not
separate according to the treatment group in PCA visualization (Fig. 2B), and no 
statistically significant lipid alterations were detected between the time points neither 
in the probiotic or placebo group (data not shown; Kekkonen et al., 2008b). The fold-
changes for each lipid species between the two time points followed normal 
distribution in both intervention groups (data not shown), which further supports the 
conclusion that the intervention did not induce systematic alterations on the lipid 
profiles.
Associations between the intestinal microbiota and
serum lipids
In addition to studying the effects of probiotic L. rhamnosus GG intervention in the 
intestinal microbiota, we investigated the co-variation of the microbiota and serum 
lipid profiles. As discussed above, our results (Table 1, Fig. 2) conclusively show that 
the probiotic intervention did not affect the lipid profiles or the microbiota beyond the 
L. rhamnosus that was ingested. Hence, the subjects from probiotic and placebo 
groups were pooled to increase the sample size and statistical power in exploring the 
associations between the intestinal microbiota and serum lipids.
Heatmap visualization of the microbiota–lipid correlations across the 22 subjects from 
2 time points revealed intestinal bacteria and serum lipids with significantly correlated 
abundance patterns (Fig. 3). In total, 86 bacterial group-lipid pairs with notable 
correlations ( ± 0.5 or higher) were identified at q < 0.05 significance level (Fig. 3). 
Among the significant correlations, 23 of the 131 genus-level taxa detectable by the
HITChip were represented (Supplemental Table S3). Most of these taxa belonged to 
Proteobacteria (6) and Firmicutes within Clostridium cluster XIVa (5) and Bacilli (3). 
From the lipid side, the vast majority of the significant correlations were attributable to 
the most dominant lipids, TGs (62%) and PCs (30%). When analyzed at the genus-
level, the significant correlations were strongly dominated by the positive correlations 
between bacteria related to Ruminococcus gnavus and different TG species (31 of 40 
significant positive correlations, average r = 0.61; Fig. 3A). Detailed analysis at the 
phylotype-level data indicated that within the R. gnavus group, two uncultured 
phylotypes, uncultured human gut bacterium JW1G3 and JW1H4a, dominated the 
correlations while the type species R. gnavus or related R. torques did not correlate 
significantly with TG or any other lipid species. Other representatives of the
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Clostridium cluster XIVa included bacteria related to Dorea formicigenerans that also 
correlated positively with four TG species (Fig. 3; average r = 0.58). The remaining 
TG correlations were negative and involved phylogenetically diverse bacteria 
(Supplemental Table S3). Also PCs correlated significantly with numerous taxa, most 
of which correlated negatively with ester- or ether linked PCs. Interestingly, a set of 
Proteobacteria (Campylobacter, Helicobacter and Moraxellaceae) with low signal 
intensities had a clear negative correlation with PC. Similarly, two Lactobacillus
species (L. rhamnosus that was ingested during the trial and L. salivarius) together 
with another group of Bacillus, Enterococcus spp., also correlated negatively with PC 
while few Firmicutes exhibited a positive correlation with this lipid species. Among the 
less abundant lipids (<10% of the total lipid pool), a positive correlation was detected 
between cholesteryl ester and Collinsella (r = 0.59; Supplemental Table S3, Fig. 5A). 
On the phylotype level, the correlation was mainly attributable to an uncultured 
bacterium clone Eldhufec074 within genus Collinsella. Another group of 
Actinobacteria, namely Actinomycetaceae, showed a significant negative correlation 
to TG and PA.
Figure 3: Correlations between intestinal genus-level phylogenetic groups 
and serum lipids.
The correlations between the intestinal bacteria and serum lipids are indicated by
colors (red: positive; blue: negative). The significant correlations (q < 0.05) are 
indicated by ‘ + ’; only lipids and bacteria with at least one significant correlation are 
shown. Hierarchical clustering of the rows and columns highlights groups of 
significantly correlated bacteria and lipids. Lipids have been named according to Lipid 
Maps (http://www.lipidmaps.org) with the following abbreviations: Cer: ceramide; 
ChoE: cholesteryl ester; lysoPC: lysophosphatidylcholine; PA: phosphatidic acid; PG: 
phosphatidylglycerol; PC: phosphatidylcholine; PS: phosphatidylserine; SM: 
sphingomyelin; TG: triglyceride. Where the fatty acid composition could not be 
determined, the total number of carbons and double bonds is indicated. The first 
number indicates the amount of carbon atoms in the fatty acid molecule, followed by 
the number of double bonds. For further details, see the Methods section.
DOI: 10.7717/peerj.32/fig-3
Hierarchical clustering and heatmap visualization of the significantly correlated lipid–
bacteria pairs revealed groups of lipids and bacteria sharing similar correlation 
patterns. A constant plaid model biclustering approach was applied to detect coherent 
groups of significantly correlating microbe–lipid pairs (see Methods). The analysis 
revealed three major clusters of significantly correlated lipid–microbe pairs 
(Supplemental Table S2). One of the observed biclusters highlights the above 
discussed positive association between bacteria related to R. gnavus and TGs.
Another TG cluster, containing highly unsaturated long-chain fatty acids, consisted of 
negatively correlating bacteria related to Megamonas hypermegale (family 
Veillonellaceae, Clostridium cluster IX) or belonging to the Actinomycetaceae. The 
third cluster contained a set of Proteobacteria (Helicobacter, Oceanospirillum and 
Moraxellaceae spp.) and bacteria related to Eubacterium cylindroides within the 
family Erysipelotrichaceae, which all correlated negatively with ether lipids.
To explore the nature of the identified lipid–microbe pairs, we quantified the 
enrichment of specific, functionally relevant lipid categories in the biclusters. In 
particular, we investigated the enrichment of lipids with even and odd number of 
carbon atoms and the degree of saturation (0, 1, or more double bonds). The origin of 
lipid can be inferred from its chemical composition: Polyunsaturated fatty acids 
(PUFAs; more than one double bond) and lipids that have uneven number of carbon 
atoms originate from plants, bacteria or marine organism as humans cannot 
synthesize them. Significant enrichment of long acyl chain (p < 0.05; Fisher exact 
test) was detected among the TG lipids that significantly correlated with bacteria 
related to R. gnavus (Supplemental Fig. S1; Supplemental Table S2). Such a positive 
association suggests a role for these R. gnavus-related bacteria in the absorption of 
dietary lipids. In support of this interpretation, TGs containing fatty acids with odd 
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number of carbons were also relatively common in this group (p = 0.1). In the other
two biclusters, no significant enrichment of odd/even carbon count or saturation level 
was detected but within the bicluster 2 (Supplemental Table S2), Actinomycetaceae
correlated exclusively with highly unsaturated PUFAs (Fig. 3).
Associations between the intestinal microbiota and 
biochemically determined serum lipids
The mean values (SD) for the major serum lipids were total cholesterol 5.10 (1.02), 
LDL cholesterol 3.00 (1.21), HDL cholesterol 1.50 (0.33) and TG 1.20 (0.71) mmol/L 
(Kekkonen et al., 2008a). No significant changes were detected in the lipids of the
probiotic or the placebo groups during the intervention (Kekkonen et al., 2008b). 
Hence, we analyzed the potential associations of the enzymatically determined major 
blood lipids with the intestinal microbiota (Table 2). A positive correlation between
bacteria related to R. gnavus and TG was observed (q < 0.01; r = 0.60; Fig. 4B), 
corroborating the association identified within the global lipid analysis. In line with the 
spectroscopic lipid analysis, representatives of Bacteroidetes and Uncultured 
Clostridiales correlated negatively and other implicated Firmicutes positively with 
enzymatically determined TG (Table 2). Representatives of Proteobacteria and 
Actinobacteria that correlated negatively with TG in the lipid profiling data did not 
correlate significantly with enzymatically determined TG. Such inconsistency may 
partly arise from methodological reasons as the enzymatic assay captures not only 
TG but also diacylglyceride, monoacylglyceride and free glycerol, while lipid profiling
captures TGs at the molecular level.
Figure 4: Association between Ruminococcus gnavus et rel. and serum 
triglyceride (TG) lipids.
The relative amounts of R. gnavus et rel. were quantified by the HITChip analysis and 
the triglyceride concentration was determined based on two independent techniques: 
A the triglyceride TG(54:5) (see Fig. 3 for explanation) by mass spectrometry
(r = 0.61); B triglyceride by an enzymatic assay (r = 0.60).
DOI: 10.7717/peerj.32/fig-4
Table 2: 
Associations between genus-level bacterial groups and enzymatically 
determined lipids.
Associations between the relative amounts of genus-level bacterial groups as 
determined by the HITChip analysis and the serum lipid concentrations are quantified 
with a biweight midcorrelation. Only significant positive and negative correlations are 
shown (q < 0.05; otherwise ‘−’). Abbreviations: Total cholesterol (TC), high-density 
lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, triglyceride (TG). 
Correlations between genus-level bacterial groups and mass spectrometry-
determined lipids are provided in Supplemental Table S3.
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Collinsella spp. and Eubacterium biforme et rel. showed statistically significant
(q < 0.05) and positive correlations to enzymatically determined total and LDL 
cholesterol (Fig. 5B; Supplemental Table S2). No other significant correlations were 
identified for total or LDL cholesterol while HDL cholesterol correlated significantly 
Phyla/Firmicute order Genus-level taxon TC LDL HDL TG
Actinobacteria Collinsella 0.56 0.57 – –
Bacilli Aneurinibacillus – – −0.58 0.50
Bacteroidetes Bacteroides plebeius et rel. – – – −0.47
Bacteroidetes Bacteroides vulgatus et rel. – – – −0.47
Bacteroidetes Tannerella et rel. – – – −0.45
Clostridium cluster XI Anaerovorax odorimutans et rel. – – −0.48 0.49
Clostridium cluster XIVa Clostridium nexile et rel. – – −0.45 –
Clostridium cluster XIVa Clostridium sphenoides et rel. – – – 0.46
Clostridium cluster XIVa Dorea formicigenerans et rel. – – −0.56 0.57
Clostridium cluster XIVa Eubacterium hallii et rel. – – – 0.47
Clostridium cluster XIVa Ruminococcus gnavus et rel. – – −0.46 0.60
Clostridium cluster XIVa Ruminococcus obeum et rel. – – −0.48 0.51
Clostridium cluster XV Anaerofustis – – −0.45 –
Clostridium cluster XVI Eubacterium biforme et rel. 0.48 0.47 – –
Clostridium cluster XVI Eubacterium cylindroides et rel. – – −0.45 –
Uncultured Clostridiales Uncultured Clostridiales I – – 0.53 −0.45
Uncultured Clostridiales Uncultured Clostridiales II – – – −0.54
with numerous taxa. Eight different Firmicutes including taxa related to Ruminococcus 
obeum and D. formicigenerans were found to correlate negatively with HDL, while
Uncultured Clostridiales I was the only taxon showing positive correlation to HDL 
(Supplemental Table S2).
Figure 5: Association between Collinsella spp. and serum cholesterol.
The relative amounts of Collinsella spp. were quantified by the HITChip analysis, and 
serum cholesterol levels were determined by two independent techniques: A
Cholesterol ester ChoE(20:5) (see Fig. 3 for explanation) by mass spectrometry 
(r = 0.59); B low-density lipoprotein (LDL) cholesterol by enzymatic assay (r = 0.57).
DOI: 10.7717/peerj.32/fig-5
Discussion
In the present study, we analyzed the effect of probiotic intake on the stability and
composition of the intestinal microbiota and of the serum lipids, and the overall 
associations between the microbiota and lipid profiles. The microbiota was analyzed 
using the HITChip, a phylogenetic microarray, providing one of the first holistic and 
community-level microbiota assessments after a probiotic intervention. The data 
published so far is largely dominated with targeted microbiota analyses that have 
reported a generic increase of lactic acid bacteria after intake of individual lactobacilli 
strains (McNulty et al., 2011; Palaria, Johnson-Kanda & O’Sullivan, 2011; Satokari et 
al., 2001; Savard et al., 2011; Vaughan, Mollet & de Vos, 1999; Yamanoa et al., 
2006). Our community-level analysis showed that the probiotic intake did not 
introduce any changes in the microbiota composition or stability except the specific 
increase of L. rhamnosus and total lactobacilli, which likely reflected the excretion of 
the ingested strain. Similarly, ingestion of a mixture of five different probiotic strains 
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did not induce any significant changes in the microbiota composition neither in adults 
nor in simplified model community in mice (McNulty et al., 2011). Even when a 
combination of probiotic and prebiotic (synbiotic) food was consumed, two studies 
based on microbiota profiling and qPCR did not identify any differences in the 
microbiota composition between placebo and treatment besides the ingested strains 
(Palaria, Johnson-Kanda & O’Sullivan, 2011; Vitali et al., 2010).
We have shown previously using the same cohort that the ingestion of L. rhamnosus
GG had apparent effects on the host immunology (Kekkonen et al., 2008b). Hence, 
our results does not support the hypothesis that probiotic bacteria would modulate the 
endogenous microbiota but rather points towards direct signaling to host or altered 
gene expression of the resident microbiota as a mode of probiotic action as recently 
proposed (McNulty et al., 2011).
Our study was carried out in healthy adults with seemingly well-established and 
balanced microbial communities. In subjects whose intestinal ecosystem is 
unbalanced e.g. due to pathogen overgrowth, gastrointestinal symptoms or recent 
intake of antibiotics, intake of probiotic bacteria may modulate the microbiota. 
Similarly, the developing microbiota of children is potentially more susceptible to 
environmental modulators including probiotics. Although substantial changes in infant 
microbiota following daily intake of L. rhamnosus GG have indeed been reported (Cox
et al., 2010), these results must be interpreted with caution as the phylogenetic 
microarray used in that study provided signals for close to 50 phyla (Midgley et al., 
2012) whereas the human intestinal ecosystem only contains a maximum of 10 phyla 
(Rajilić-Stojanović, Smidt & de Vos, 2007).
To the best of our knowledge, this cohort is the first addressing the potential impact of 
probiotics on global serum lipid profiles in adults. Daily intake of L. rhamnosus GG for 
three weeks did not introduce any consistent alterations in the serum lipids or in the
biochemically determined cholesterol and triglyceride levels of the healthy,
normolipidemic adults analyzed in this and previous study (Kekkonen et al., 2008a). 
Probiotic bacteria have been suggested as a potential non-drug treatment to lower 
serum cholesterol levels based on their in vitro described ability to deconjugate bile 
acids and directly assimilate cholesterol. A recent meta-analysis implies that probiotic 
intake can lower the total and LDL cholesterol (Guo et al., 2011), although numerous 
human studies have failed to observe any effects on serum lipids after probiotic intake
(see e.g. Sadrzadeh-Yeganeh et al., 2010; Pereira & Gibson, 2002). One explanation 
for the controversy is that similarly to the strain-specificity of the immunomodulatory 
effects of probiotics (Kekkonen et al., 2008b), also their effects on lipid metabolism 
are likely to vary between different strains. In atopic infants the consumption of L.
rhamnosus GG supplemented formulas for several months resulted in a reduced
proportion of α-linolenic acid and of total n-3 PUFAs, leading to increased n-6 to n-3 
PUFA ratio in sera of probiotic-fed infants (Kankaanpää et al., 2002). Decrease of n-3 
fatty acids has negative health implication, underlining the need for more in vivo
research to specify the bacterial strains and target population where probiotics can 
have beneficial effects on the host lipid metabolism.
Our data indicates that the variation of the intestinal microbiota is considerably higher 
across the individuals than the variation in serum lipid profiles, highlighting the tight 
homeostatic control of systemically circulating lipids. The intestinal microbiota is 
known to play an important role in the regulation of systemic lipid metabolism (Martin
et al., 2007; Velagapudi et al., 2010). In this study, we identified several novel 
associations between the human intestinal commensals and serum lipids. From the 
lipid side, TGs (62%) and PCs (30%) dominated the significant lipid–microbe 
correlations. TGs are used for energy storage while PCs are abundant constituents of 
cell membranes. Both of these abundant lipid classes were affected upon colonization
of germ-free mice (Velagapudi et al., 2010). The most prominent correlation was 
between TGs and uncultured phylotypes related to R. gnavus that belong to family
Ruminococcaceae in Clostridium cluster XIVa. Two characterized species within the 
group, R. gnavus and R. torques, have been implicated in intestinal disorders as they 
appeared to be overrepresented both in IBS (Kassinen et al., 2007; Rajilić-Stojanović
et al., 2011) and in IBD (Joossens et al., 2011; Prindiville, Cantrell & Wilson, 2004). 
The TG lipids that were positively associated with R. gnavus-related phylotypes were 
enriched with polyunsaturated and odd-chain fatty acids. Since the odd-chain fatty 
acids are not synthesized in the body, these positive associations suggest that the 
implicated bacteria facilitate the absorption of polyunsaturated dietary lipids. 
Moreover, it cannot be excluded that these bacteria are even involved in their 
biosynthesis as related R. obeum together with other Firmicutes are among the 
intestinal bacteria capable of producing isomers of conjugated linoleic acids (CLA; 
McIntosh et al., 2009).
Triglycerides carry different types of fatty acids, and accordingly not all TGs displayed 
the same pattern regarding microbial correlations. For example, bacteria related to D. 
formicigenerans showed positive association to saturated triglycerides with a small 
carbon number, i.e. including palmitic acid. These fatty acids are mainly produced de
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novo in the liver (Westerbacka et al., 2010; Kotronen et al., 2009). D. formicigenerans
produces formate and acetate that are precursors of hepatic lipogenesis. Recent 
metaproteomic work verifies that the acetate kinases involved in acetate production 
are highly expressed in the intestinal ecosystem (Kolmeder et al., 2012), suggesting 
that several intestinal bacteria have potential to regulate lipogenesis. On the other 
hand, Actinomycetaceae were inversely associated with TGs containing highly 
unsaturated triglycerides with a high carbon number. Such TGs carry physiologically 
important fatty acids such as C22:6 (docosahexanoic acid) and C20:4 (arachidonic 
acid). Both are important cell membrane components, the former especially in visual 
and neural tissues, and the latter is involved in inflammatory signaling. While not 
much is known about the intestinal Actinomycetaceae, both commensal and 
pathogenic forms of these Actinobacteria are abundant in the oral cavity.
We identified multiple taxa correlating negatively with normal or ether linked forms of 
PC. Dietary PC was recently identified as compound that after conversion by the 
intestinal microbiota promotes heart disease (Wang et al., 2011). Unfortunately, that 
study did not address the identity of bacteria involved in the metabolism of dietary PC,
but our data suggest that different Firmicutes, Proteobacteria and Fusobacteria may 
participate in this metabolic conversion (Fig. 3). Remarkably, the presence of serum 
ether PCs was negatively associated with various taxa, mainly with Gram-negative
genera that include pathogens and commensals, such as Helicobacter,
Moraxellaceae and Campylobacter. Among the ether lipids, plasmalogens, known as 
endogenous antioxidants (Wallner & Schmitz, 2011), are the most abundant. Their 
negative association with Proteobacteria could indicate that the implicated bacteria 
may induce oxidative stress in host cells, leading to depletion of plasmalogens. In 
support of this hypothesis, lipopolysaccharide (LPS), a ubiquitous and toxic surface 
component of Gram-negative bacteria, induces oxidative stress in mammalian cell 
cultures (Aly, Lightfoot & El-Shemy, 2010).
Finally, we identified positive correlation between the abundance of serum cholesterol 
and genus Collinsella (Actinobacteria, family Coriobacteriacea). Biochemical lipid 
analysis indicated that Collinsella spp. together with bacteria related to E. biforme
correlated specifically with total cholesterol and LDL but not HDL. To our knowledge, 
our work provides the first in vivo evidence about the implication of Coriobacteriacea
in human lipid metabolism. Our present findings are supported by the data generated 
with rodent models. In a hamster model, the proportion of Coriobacteriaceae showed
high positive correlation with non-HDL plasma cholesterol levels and reacted to the 
intake of dietary lipids (Martinez et al., 2009). In a mouse model, a strong positive 
correlation between Coriobacteriaceae and hepatic triglycerides was identified (Claus
et al., 2011), providing cumulative indication for the involvement of Coriobacteriaceae
in mammalian lipid metabolism. While only one taxon (Collinsella) correlated 
statistically significantly with cholesterol in the lipid profiling data, numerous taxa 
showed significant correlation to enzymatically determined HDL cholesterol. This may 
arise from technical differences, as the lipid profiling does not quantify free cholesterol
but its derivative cholesteryl ester, where cholesterol is esterified to long-chain fatty 
acids. All taxa that were associated with both HDL cholesterol and TG had opposite 
correlation with these lipids (Supplemental Table S2), in accordance with the fact that 
serum TG and HDL show strong inverse relationship, and their ratio is used as an 
atherogenic index that predicts cardiovascular risk (Jeppesen et al., 1997). Hence, 
identification of bacteria that potentially affect the athreogenic index may provide 
important clinical implications for dyslipidemic individuals.
While good correspondence between the HITChip and pyrosequencing studies have 
been previously demonstrated, the main advantage of the HITChip microarray 
compared to the pyrosequencing studies is that the microarray technology provides 
very standardized and cost-efficient tools for deep and reproducible analysis of 
intestinal microbiota including phylotypes that are only present in low concentrations 
(Claesson et al., 2009; Salonen et al., 2012). We expect that our major findings, the 
associations between specific lipid species and bacteria related to Collinsella or R.
gnavus could be detected also in a standard pyrosequencing study due to the
relatively high abundance of these organisms. However, the associations involving 
less abundant taxa (Bacilli, Proteobacteria, Actinomycetaeae) would likely have been 
missed with conventional sequencing depth.
In summary, quantitative analysis of high-throughput profiling data identified several 
significant correlations between the intestinal microbiota and serum lipids. These 
results partly confirm and extend previous observations in animal studies, and provide 
hypotheses for follow-up studies in humans. It is important to note, however, that the 
present analysis is based on a Finnish cohort and only two time points, and does not 
consider causal relationships between these variables. Therefore it cannot be 
excluded that some of the observed correlations may be associated with the diet or 
other confounding variables that simultaneously affect both lipid and microbiota 
profiles. However, as all subjects ate their habitual diets, individual food components 
are not likely to cause systematic bias to the observed lipid–microbe correlations, 
which is further supported by the observation of distinct groups of correlated lipid–
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microbe pairs in the bicluster analysis. It can also be ruled out that the intervention 
would have caused the correlations as control measurements from the baseline were 
included, the ingested probiotics L. rhamnosus GG did not correlate significantly with 
any serum lipid, and the drink did not otherwise alter the microbiota. Confirmation of 
the findings in an independent cohort and a more thorough longitudinal analysis will 
be necessary to assess the effect of external variables on the microbiota–lipid 
correlations and their potential causal associations. None of the implicated bacterial 
taxa are functionally characterized, and thus the potential mechanisms of how human
intestinal bacteria relate to the host lipid metabolism are currently unknown. Among 
the potential mechanisms, bacterial modification of the bile acid pool is by far the best 
characterized. Collinsella spp., R. gnavus as well as the genus Eubacterium are 
among the intestinal bacteria capable of deconjugating bile acids (Lepercq et al., 
2004). Bile acids are cholesterol-derived detergents that play a central role in the 
absorption of fat in the intestine but also in signaling with systemic endocrine 
functions (Swann et al., 2011). It has been known for long that intestinal bacteria can
chemically modify bile acids but recent work suggest that the microbiota may also 
control their production and degradation (Antunes et al., 2011). In mice the intestinal 
bacteria profoundly affect the emulsification, absorption and transport of dietary fat as 
well as their storage and peroxidation through the metabolic and signaling properties 
of bile acids (Martin et al., 2007).
Conclusion
Our data supports the concept that the overall lipid content in human serum is a 
composite of host and microbial metabolic activity, and the intestinal commensals are 
implicated in the metabolism of various lipid species that human body utilizes for 
membranes, energy storage and signaling. Considering that a single gene in an 
intestinal bacterium could alter host fatty acid composition (Rosberg-Cody et al., 
2011), we can only envisage the metabolic capacity and the functional consequences 
from the million genes in the intestinal microbiome. As epidemiological data do not 
support a link between dietary cholesterol and serum cholesterol levels (Lecerf & de 
Lorgeril, 2011), the role of genetic factors in the individual variability of cholesterol 
levels is evident. Identification of the bacteria and their mechanisms that regulate host 
fatty acid and lipid metabolism have considerable potential for clinical implications 
due to the profound role of these molecules for instance in cardiovascular disease 
and regulation of inflammatory cytokine signaling (Calder, 2011). Future trials 
involving controlled diet and dyslipidemic individuals will provide further insights on 
the role of intestinal microbes on human lipid metabolism.
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